60025-06-1 Usage
General Description
4,6-dichloro-5-acetylpyrimidine is a chemical compound with a molecular formula C6H3Cl2N2O. It is a yellow crystalline solid with a molecular weight of 189.01 g/mol. 4,6-dichloro-5-acetylpyrimidine is used as a building block in the synthesis of pharmaceuticals and agrochemicals. It is also used as an intermediate in the production of various dyes and pigments. The presence of both acetyl and chloro groups in its structure makes 4,6-dichloro-5-acetylpyrimidine a versatile starting material for the construction of more complex organic molecules. 4,6-dichloro-5-acetylpyrimidine is commonly utilized in the research and development of new chemical products and processes. However, it is important to handle and store 4,6-dichloro-5-acetylpyrimidine with care as it is potentially hazardous if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 60025-06-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,0,2 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 60025-06:
(7*6)+(6*0)+(5*0)+(4*2)+(3*5)+(2*0)+(1*6)=71
71 % 10 = 1
So 60025-06-1 is a valid CAS Registry Number.
60025-06-1Relevant articles and documents
1H-PYRAZOLO[3,4-D]PYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF PLATINUM-RESISTANT CANCER
-
, (2021/06/26)
The invention relates to compounds of formula (I) and related compounds and their use in the treatment of cancer, especially platinum resistant cancer. The invention also provides a treatment comprising administration of a compound of formula (I) and a pl
BICYCLIC HETEROCYCLE DERIVATIVES AND THEIR USE AS GPCR MODULATORS
-
Page/Page column 57-58, (2010/04/03)
The present invention relates to Bicyclic Heterocycle Derivatives of Formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a diabetic
BICYCLIC HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS
-
Page/Page column 79, (2008/06/13)
-